Lipocine Inc (LPCN)
5.24
+0.39
(+8.04%)
USD |
NASDAQ |
May 09, 16:00
5.21
-0.03
(-0.57%)
After-Hours: 20:00
Lipocine Market Cap: 27.85M for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 27.85M |
| May 08, 2024 | 25.78M |
| May 07, 2024 | 26.63M |
| May 06, 2024 | 26.15M |
| May 03, 2024 | 24.88M |
| May 02, 2024 | 24.98M |
| May 01, 2024 | 25.04M |
| April 30, 2024 | 24.56M |
| April 29, 2024 | 25.14M |
| April 26, 2024 | 25.50M |
| April 25, 2024 | 24.19M |
| April 24, 2024 | 23.60M |
| April 23, 2024 | 25.52M |
| April 22, 2024 | 26.95M |
| April 19, 2024 | 28.01M |
| April 18, 2024 | 28.92M |
| April 17, 2024 | 28.28M |
| April 16, 2024 | 25.30M |
| April 15, 2024 | 28.47M |
| April 12, 2024 | 30.88M |
| April 11, 2024 | 34.07M |
| April 10, 2024 | 34.61M |
| April 09, 2024 | 30.67M |
| April 08, 2024 | 27.96M |
| April 05, 2024 | 25.52M |
| Date | Value |
|---|---|
| April 04, 2024 | 24.51M |
| April 03, 2024 | 26.21M |
| April 02, 2024 | 26.42M |
| April 01, 2024 | 28.17M |
| March 28, 2024 | 27.64M |
| March 27, 2024 | 27.26M |
| March 26, 2024 | 26.63M |
| March 25, 2024 | 23.39M |
| March 22, 2024 | 21.48M |
| March 21, 2024 | 21.85M |
| March 20, 2024 | 22.49M |
| March 19, 2024 | 22.65M |
| March 18, 2024 | 23.87M |
| March 15, 2024 | 24.45M |
| March 14, 2024 | 24.93M |
| March 13, 2024 | 25.46M |
| March 12, 2024 | 21.05M |
| March 11, 2024 | 19.19M |
| March 08, 2024 | 19.19M |
| March 07, 2024 | 19.30M |
| March 06, 2024 | 19.03M |
| March 05, 2024 | 19.35M |
| March 04, 2024 | 19.40M |
| March 01, 2024 | 20.36M |
| February 29, 2024 | 20.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.996M
Minimum
Nov 15 2019
185.16M
Maximum
Feb 10 2021
63.24M
Average
48.68M
Median
Feb 03 2023
Market Cap Benchmarks
| Alpine Immune Sciences Inc | 4.252B |
| Eliem Therapeutics Inc | 248.92M |
| NovaBay Pharmaceuticals Inc | 2.688M |
| Palatin Technologies Inc | 37.92M |
| iBio Inc | 6.550M |
Market Cap Related Metrics
| PEG Ratio | -0.0475 |
| Price to Book Value | 1.368 |
| Price | 5.24 |
| Earnings Yield | -58.21% |
| PEGY Ratio | -0.0475 |